Month: February 2021

EDISON, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) — Hepion Pharmaceuticals, Inc. (NASDAQ:HEPA), a clinical stage biopharmaceutical company focused on the development of therapeutic drugs for the treatment of liver disease arising from non-alcoholic steatohepatitis (“NASH”), today announced the pricing of its underwritten public offering of 44,200,000 shares of its common stock at a public offering price of $2.00 per share, for gross proceeds of $88.4 million before deducting underwriting discounts, commissions and other offering expenses. All of the shares of common stock are being offered by the Company.ThinkEquity, a division of Fordham Financial Management, Inc., is acting as sole book-running manager for the offering.The offering is expected to close on February 18, 2021, subject to satisfaction of customary closing conditions.Hepion...

EDMONTON, Alberta and NEW YORK, Feb. 16, 2021 (GLOBE NEWSWIRE) — TSX, NYSE: STNGlobal engineering and design firm Stantec has signed an agreement (set to close on March 1, 2021) to acquire GTA Consultants (GTA), an Australia-based transportation planning and engineering firm with a diverse portfolio of long-standing clients across the public and private sectors.GTA provides award-winning expertise in transportation advisory, planning and analytics; transport engineering; and technical design, having worked on many of Australia’s largest and most iconic transportation projects. The financial terms of the transaction were not disclosed.“GTA adds immediate depth to our existing transportation service offerings in Australia and New Zealand, enhancing our transportation planning, advisory planning, and design capabilities in regions...

BERWYN, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) — Annovis Bio Inc. (NYSE American: ANVS), a clinical-stage drug platform company addressing Alzheimer’s disease (AD), Parkinson’s disease (PD) and other neurodegenerative diseases, today announced that Maria Maccecchini, Ph.D., Founder and Chief Executive Officer, will present at the BIO CEO & Digital Conference, available online February 16-18, 2021. Annovis Bio’s presentation will be accessible on demand during the virtual event for all registered attendees.Event registration is available at https://www.bio.org/events/bio-ceo-investor-digital-conferenceAbout Annovis BioHeadquartered in Berwyn, Pennsylvania, Annovis Bio, Inc. (Annovis) is a clinical-stage, drug platform company addressing neurodegeneration, such as Alzheimer’s disease (AD), Parkinson’s disease (PD) and...

Seoul, Korea, Feb. 16, 2021 (GLOBE NEWSWIRE) — Seoul, South Korea – February 16, 2021– GRAVITY Co., Ltd. (NasdaqGM: GRVY) (“Gravity” or “Company”), a developer and publisher of online and mobile games based in South Korea, today announced its selected preliminary unaudited financial result for the fourth quarter ended December 31, 2020 and business updates.PRELIMINARY UNAUDITED FOURTH QUARTER 2020 FINANICIAL RESULTRevenue and operating profitTentative consolidated revenue for the fourth quarter of 2020 is KRW 112 billion and operating profit is KRW 27 billion. The preliminary fourth quarter result is mainly attributed by decreased revenues from Ragnarok Origin in Korea, Ragnarok Online in Thailand and Ragnarok M: Eternal Love representing a 14.7% decrease QoQ. This decrease is partially offset by increased revenues from Ragnarok X:...

MT. LAUREL, N.J., Feb. 16, 2021 (GLOBE NEWSWIRE) — inTEST Corporation (NYSE American: INTT), a global supplier of innovative test and process solutions for use in manufacturing and testing across a wide range of markets, including automotive, defense/aerospace, energy, industrial, semiconductor and telecommunications, announced today that it continues to experience strong growth in its automotive and electric vehicle (EV) market penetration. “We are making great strides in this emerging market,” noted Nick Grant, inTEST President and CEO. “inTEST’s Thermal Products Segment’s subsidiary, Ambrell Corporation, continues to make strong contributions to the Company’s diversification strategy, and we see the EV market as one of the early successes in our renewed focus on end markets and applications.”Ambrell is a leader in the induction...

SAN DIEGO, Feb. 16, 2021 (GLOBE NEWSWIRE) — Metacrine, Inc. (Nasdaq: MTCR), a clinical-stage biopharmaceutical company focused on discovering and developing differentiated therapies for patients with liver and gastrointestinal diseases, today announced that the Journal of Hepatology has published the results from the company’s 12-week, randomized, placebo-controlled Phase 1b study of MET409, the company’s lead farnesoid X receptor (FXR) agonist, in patients with non-alcoholic steatohepatitis (NASH).“The publication of our Phase 1b study data in this highly regarded, peer-reviewed journal further underscores the promise of an optimized FXR to treat patients with NASH, a potentially life-threatening liver disease with no approved treatments,” said Hubert C. Chen, M.D., chief medical officer of Metacrine. “MET409 has demonstrated improvements...

WAYNE, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) — Teleflex Incorporated (NYSE: TFX), has been recognized as part of Forbes’ list of America’s Best Employers 2021. The company ranked #26 out of 500 employers in the Mid-Sized Employers category and #2 in the Health Care Equipment & Services category. This prestigious award is presented by Forbes and Statista Inc., the world-leading statistics portal and industry ranking provider. The awards list can be viewed by visiting www.teleflex.com/usa/en.Forbes and Statista selected the America’s Best Employers 2021 through an independent survey applied to a vast sample of more than 50,000 American employees. Employees who participated in the survey work for companies with more than 1,000 employees based in the US. Across 25 industry sectors, 1,000 employers have been awarded, 500 large employers...

WAYNE, Pa., Feb. 16, 2021 (GLOBE NEWSWIRE) — Liam Kelly, Chairman, President and CEO, Teleflex Incorporated (NYSE: TFX), is scheduled to speak at the Raymond James 42nd Annual Institutional Investors Conference on Tuesday, March 2, 2021 at 12:30 p.m. (ET).A live audio webcast of the conference presentation, along with the accompanying slide presentation, will be available on the investor portion of the Teleflex website at www.teleflex.com.About Teleflex IncorporatedTeleflex is a global provider of medical technologies designed to improve the health and quality of people’s lives. We apply purpose driven innovation – a relentless pursuit of identifying unmet clinical needs – to benefit patients and healthcare providers. Our portfolio is diverse, with solutions in the fields of vascular access, interventional cardiology and radiology,...

VANCOUVER, British Columbia, Feb. 16, 2021 (GLOBE NEWSWIRE) — K92 Mining Inc. (“K92” or the “Company”) (TSX: KNT; OTCQX: KNTNF) is pleased to announce that on February 12, 2020, a State Delegation, including the Honorable James Marape, Prime Minister of Papua New Guinea, the Honorable Peter Numu, Governor of Eastern Highlands Province, and the Honorable Johnson Tuke, Minister for Mining and local Member of Parliament for Kainantu, met with representatives of K92. Highly productive meetings, presentations and community events were held in Goroka and Kainantu townships, followed by a site visit to K92’s Kainantu Gold Mine in Eastern Highlands Province, PNG.In Kainantu township, K92 announced a contribution of PGK1 million (US$285k) towards building a new market to support local businesses and commerce, and the receipt of approval...

ROUYN-NORANDA, Quebec, Feb. 16, 2021 (GLOBE NEWSWIRE) — Radisson Mining Resources Inc. (“Radisson” or the “Company”) (TSX.V: RDS, OTC: RMRDF) announces that it is making a number of changes to its board and management team, while continuing to strengthen its technical team. Drilling has continued to demonstrate the robust grade and scale potential at O’Brien. The Company believes that the changes to the team and the addition of three new experienced directors will streamline decision making and significantly enhance the Company’s technical and financial strength, in turn positioning the company for the next phase of value creation at O’Brien.Michael Gentile, previously Strategic Advisor to the Company has been appointed as a Director of the Company effective today.In addition, two new Directors with a strong mining industry background...